Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Travere Therapeutics (TVTX) Insider Trading & Ownership

$13.99
0.00 (0.00%)
(As of 10/1/2024 ET)

Travere Therapeutics (NASDAQ:TVTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.75%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$1.38 M

TVTX Insider Buying and Selling by Quarter

Travere Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/30/2024Jeffrey A MecklerDirectorSell40,000$14.06$562,400.00  
9/9/2024Christopher R ClineCFOSell2,490$11.52$28,684.80  
9/9/2024Eric M DubeCEOSell21,125$11.52$243,360.00  
9/9/2024Jula InrigInsiderSell2,191$11.52$25,240.32  
9/9/2024William E RoteSVPSell4,387$11.52$50,538.24  
9/4/2024Christopher R ClineCFOSell514$9.51$4,888.14  
[Urgent!] Web3 Could Send One Crypto Soaring (Ad)

Venture Capital corporations and blockchain funds are pouring money into Web3 gaming. And there's one little-known crypto coin that's poised for RAPID growth as we see Web3 expand over the next few years.

Click here to review my research and unique strategy to score potential profits from this under-the-
4/11/2024Christopher R ClineCFOSell54$6.74$363.96  
2/1/2024Christopher R ClineCFOSell3,818$8.53$32,567.54  
2/1/2024Eric M DubeCEOSell19,122$8.70$166,361.40  
2/1/2024Peter HeermaInsiderSell4,195$8.53$35,783.35  
2/1/2024Sandra CalvinCAOSell2,820$8.53$24,054.60  
2/1/2024William E RoteSVPSell4,764$8.71$41,494.44  
1/23/2024Christopher R ClineCFOSell853$9.07$7,736.71  
1/23/2024Elizabeth E ReedSVPSell2,062$8.96$18,475.52  
1/23/2024Eric M DubeCEOSell7,873$8.96$70,542.08  
1/23/2024Peter HeermaInsiderSell1,559$9.07$14,140.13  
1/23/2024Sandra CalvinCAOSell910$9.07$8,253.70  
1/3/2024Jula InrigInsiderSell2,069$9.48$19,614.12  
10/3/2023Peter HeermaInsiderSell3,091$8.25$25,500.75  
(Data available from 1/1/2013 forward)

TVTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Travere Therapeutics includes Christopher R Cline, Elizabeth E Reed, Eric M Dube, Jeffrey A Meckler, Jula Inrig, Laura Clague, Peter Heerma, Sandra Calvin, Steve Aselage, and William E Rote. Learn more on insiders at TVTX.

3.75% of Travere Therapeutics stock is owned by insiders. Learn more on TVTX's insider holdings.

The following insiders have sold TVTX shares in the last 24 months: Christopher R Cline ($142,719.90), Elizabeth E Reed ($89,789.77), Eric M Dube ($983,379.28), Jeffrey A Meckler ($562,400.00), Jula Inrig ($87,412.69), Peter Heerma ($226,181.04), Sandra Calvin ($95,705.29), and William E Rote ($163,064.33).

Insiders have sold a total of 170,740 Travere Therapeutics shares in the last 24 months for a total of $2,350,652.30 sold.



This page (NASDAQ:TVTX) was last updated on 10/2/2024 by MarketBeat.com Staff
From Our Partners